Alisporivir for the treatment of chronic HCV

Author： Azzaroli Francesco   Turco Laura   Lisotti Andrea   Cecinato Paolo   Calvanese Claudio   Buonfiglioli Federica   Cevenini Monica   Montagnani Marco   Mazzella Giuseppe  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.7, Iss.1, 2012-01, pp. : 9-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential role for statins in the treatment of chronic HCV infection

By Zhu Qianqian   Han Qunying   Liu Zhengwen  

Future Virology, Vol. 8, Iss. 8, 2013-08 ,pp. : 727-729

Future Medicine

Access to resources Recommend Favorite

Update on alisporivir in treatment of viral hepatitis C

By Flisiak Robert   Jaroszewicz Jerzy   Flisiak Iwona   ŁŁapińński Tadeusz  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 375-382

Informa Healthcare

Access to resources Recommend Favorite

The monoclonal antibody XTL 002 [HCV-AB68] has potential in the treatment of chronic hepatitis C virus (HCV) infection

By  

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Updated practice guidelines for the treatment of chronic hepatitis C virus (HCV) in Sweden have been developed by a national expert panel.

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 439, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Future Promise of siRNA and Other Nucleic Acid Based Therapeutics for the Treatment of Chronic HCV

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 43-56

Bentham Science Publishers

Access to resources Recommend Favorite